Tuesday, April 16, 2024 3:29:22 AM
As of November 14, 2023, the Issuer was unable to obtain any updates other then there
were no quarterly financials available due to the closure of Mr. Siclari offices and the entities were engaging replacement
accountants; additionally we were advised on November 20, 2023, there was no possibility of any financial information until
the annual reports were completed after 31 December 2023 due to the change in the accountants. Therefore, based on advise
of counsel, the Issuer will be reporting the information available and not reporting any income, change in cash flow for the
period ending 30 September 2023 and will report only the financials for Gaensel Energy Group, Inc., the parent, and for its
Metro VR Studio and Protonstar investment.
On December 30, 2023, the Board of Directors convened and terminated all Stock Purchase Agreements with
SSCB Swiss Stem Cell Biotech, Switzerland
RE-YOU SUISSE, Switzerland
Oversky SL,Tenerife, Spain
Suite 110 , Milan, Italy.
Esarc-Hi-Tech, Milan, Italy
Automecc SRL, Milan, Italy
Consorzio Green Solution & GNL, Milan, Italy
LB Energia, Milan, Italy
Le Roy srl, Milan, Italy
International SRL, Milan, Italy
As of the current date of this filing, the Management is currently in negotiations for a change in control where it will acquire
100% of the Preferred Shares held by Global Development Advisors Limited and enter into agreement(s) for new business
development for the Company. The Management will be retaining an International Accounting Firm to provide Audited
Financial Statements on or before 30 April 2024 in lieu of an Account in Respect to Current Information. The Issuer will make
appropriate Change of Control Supplemental Filings and required forms by OTC Markets immediately upon the completion of
the Change of Control.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM